Neurobehavioral effects in HIV-Positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Lawler, Kathy ^c   Jeremiah, Kealeboga ^e   Mosepele, Mosepele ^b,c   Ratcliffe, Sarah J ^c   Cherry, Catherine ^e,f   Seloilwe, Esther ^a   Steenhoff, Andrew P ^c,d  

^a UNIVERSITY OF BOTSWANA   (Botswana)

^b PRINCESS MARINA HOSPITAL   (Botswana)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e MONASH UNIVERSITY   (Australia)

^f ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADULT; ARTICLE; BOTSWANA; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; STRUCTURED INTERVIEW; TREATMENT RESPONSE; BEHAVIOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; MENTAL DISEASE; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; TASK PERFORMANCE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BEHAVIOR; BOTSWANA; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; TASK PERFORMANCE AND ANALYSIS; YOUNG ADULT;

EID: 79951989642     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017233     Document Type: Article

References (45)

1. UNAIDS,NACA Botswana-2010 Country Progress Report, UNAIDS website. Available: http://www.unaids.org/en/CountryResponses/Countries/botswana.asp. Accessed 2011 Jan 30.
2. Scaravilli F, (1993) Neuropathology of HIV infection. London Springer-Verlag.
3. An SF, Groves M, Gray F, Scaravilli F, (1999) Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. Journal of Neuropathology and Experimental Neurology 58 (11): 1156-1162 PMID 10560658.
4. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, et al. (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789-1799 DOI:10.1212/01.WNL.0000287431.88658.8b.
5. Osowiecki, DM, Cohen RA, Morrow KM, Paul RH, Carpenter CC, et al. (2000) Neurocognitive and psychological contributions to quality of life in HIV-1 infected women. AIDS 14: 1327-1332 PMID 10930146.
6. Heaton RK, Marcotte TD, Rivera Mindt M, Sadek J, Moore D, et al. (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. J IntNeuropsychol Soc 10: 317-331 PMID 15147590.
7. Dawes S, Suarez P, Casey CY, Cherner M, Marcotte TD, et al. (2008) Variable patterns of neuropsychological performance in HIV-1 infection. Journal of Clinical and Experimental Neuropsychology 30 (6): 613-636 PMID 18608689.
8. Heaton RK, Franklin D, Clifford D, Woods S, Rivera Mindt M, (2009) HIV-associated neurocognitive impairment remains prevalent in the era of combination art: the Charter study. Paper presented at the 16th Conference on Retroviruses and Opportunistic Infections, Montreal. retroconference.org/2009/display.asp?page = 396.
9. Bhaskaran K, Mussini C, Antinori A, Walker SA, Dorrucci M, the CASCADE Collaboration (2008) Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Annal of Neurology 63 (2): 213-221 PMID 17894380.
10. Wright E, Brew A, Arayawichanon A, Robertson K, Samintharapanya K, et al. (2008) Neurological disorders are prevalent in HIV positive outpatients in the Asia-Pacific region. Neurol 71 (1): 50-56 PMID 18591505.
11. Sacktor N, Wong M, Nakasuija N, Skolasky RL, Selnes O, et al. (2005) The international HIV dementia scale: a rapid new screening test for HIV dementia. Aids 19 (13): 1367-1374.
12. Clifford DB, Mitike MT, Mekonnen Y, Zhang J, Zenebe G, et al. (2007) Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. Journal of Neurovirology 13 (1): 67-72.
13. Wong M, Robertson K, Nakasujja N, Skolasky R, Musisi S, et al. (2007) Frequency of and risk factors for HIV dementia in sub-Saharan Africa. Neurol 68 (5): 350-355.
14. Kanmogne GD, Kuate CT, Cysique LA, Fonsah JY, Eta S, et al. (2010) HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon, BMC Neurol 10: 60.
15. Nakasujja N, Wong M, Robertson K, McArthur J, Sacktor N, (2004) HIV-associated neurological complications among HIV-seropositive individuals in Uganda. Neurology 62: A44.
16. Gupta JD, Satishchandra P, Kumarpillai G, Wilkie F, Waldrop-Valverde D, et al. (2007) Neuropsychologcial deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J of NeuroVirology 13: 195-202.
17. Heaton RK, Cysique L, Hua J, Shai C, Xin Y, the San Diego HIV NRCG, (2008) Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J of NeuroVirology 14: 536-549.
18. Joska JA, Westgarth-Taylor J, Myer L, Hoare J, Thomas KG, Combrinck M, Paul RH, Stein DJ, Flisher AJ, (2010) Characterization of HIV-associated neurocognitive disorders among individuals starting antriretroviral therapy in South Africa. AIDS Behav, 2010 Jul Epub ahead of print.
19. Cysique LA, Brew J, (2009) Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychology Review 19 (2): 169-185.
20. Cysique LA, Letendre SL, Ake C, Jin H, Franklin DR Jr, the HIV Neurobehavioral Research Center Group (2010) Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS 24 (7): 983-990.
21. Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, et al. (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26: 307-319.
22. Cysique LA, Maruff P, Brew BJ, (2006) Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology 66: 1447-1450.
23. Robertson K, Liner J, Heaton R, (2009) Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev 19: 232-249.
24. Maj M, Satz P, Janssen R, Aaudig M, Starace F, et al. (1994) WHO Neuropsychiatric AIDS study, cross-sectional phase II: neuropsychological and neurological findings. Archives of General Psychiatry 51 (1): 51-61.
25. Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, et al. (2006) Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67 (2): 311-314.
26. Liner KJ II, Hall CD, Robertson KR, (2007) Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease. J of NeuroVirology 13: 291-304.
27. Lawler K, Mosepele M, Ratcliffe S, Seloilwe E, Steele K, et al. (2010) Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. J Intl AIDS Soc 13 (1): 15.
28. Wechsler D, Wechsler Adult Intelligence Scale-Third Edition (1997) New York The Psychological Corporation.
29. Woods SP, Scott JC, Sires DA, Grant I, Heaton RK, et al. (2005) Action (verb) fluency: Test-retest reliability, normative standards, and construct validity. Journal of the International Neuropsychological Society 11: 408-415.
30. Cysique LA, Jin H, Franklin DR Jr, Morgan EE, Shi C, the HNRC Group (2007) Neurobehavioral effects of HIV-1 infection in China and the United States: A pilot study. J of International Neuropsych Soc 13: 781-790.
31. Robertson KR, Nakasujja N, Wong M, Musisi S, Katabira E, et al. (2007) Pattern of neuropsychological performance among HIV positive patients in Uganda, BMC Neurology 7: 8.
32. Reitan RM, Wolfson D, (1985) The Halstead-Reitan neuropsychological test battery. Tucson, AZ Neuropsychology Press.
33. Maj M, D'Elia L, Shatz P, et al. (1993) Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: A WHO study, Archives of Clinical Neuropsychology 8: 123-135.
34. Lafayette Instrument Grooved Peg Board Test, Lafayette, IN, Lafayette Instruments website. Available: www.lafayetteinstrument.com/. Accessed 2011 Jan 30.
35. Spitzer R, Williams J, Kroenke D, Linzer M, deGruy FV 3rd, et al. (1994) Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD study.JAMA 272: 1749-1756.
36. American Psychiatric Association (1994) Diagnostic and statistical manual for mental disorders-fourth edition (DSM-IV).
37. Tommasello AC, Gills LM, Lawler JT, Bujak GJ, (2006) Characteristics of homeless HIV-positive outreach responders in urban US and their success in primary care treatment. AIDS Care 18 (8): 911-917.
38. Lawler K, Mosepele M, Seloilwe E, Ratcliffe S, Steele K, et al. (2011) Depression among HIV-positive individuals in Botswana: a behavioral surveillance. AIDS Behav 15 (1): 204 Epublished ahead of print 2009, DOI 10.1007/s10461-009-9622-2.
39. Hua J, Atkinson JH, Xin Y, Heaton RK, Chuan SJ, HNRC China collaboration group (2006) Depression and suicidality in HIV/AIDS in China. J of Affective Disorders 94: 269-275.
40. Botswana National HIV/AIDS Treatment Guidelines Department of HIV/AIDS Prevention and Care, Botswana. 2008. AIDSTAR-One website. Available: http://www.aidstar-one.com/treatment-documents. Accessed 2011 Jan 30.
41. Letendre S, Marquie BJ, Caparelli E, Best B, Clifford D, et al. (2008) Validation of the CNS penetration effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65 (1): 65-70.
42. Tozzi V, Balestra P, Salvatori M, Vlassi C, Liuzzi G, et al. (2009) Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders. JAIDS 52 (1): 56-63.
43. Suarez SV, Stankoff B, Conquy L, Rosenblum O, Seilhean D, (2000) Similar subcortical pattern of cognitive impairment in AIDS patients with and without dementia. European Journal of Neurology 7: 151-158.
44. Sacktor N, Nakasujja N, Clifford D, (2007) HIV-associated cognitive impairment in sub-Saharan Africa-the potential effect of Clade diversity. Nat Clin Pract Neurol 3 (8): 436-443.
45. Livingston J, (2009) Suicide, risk, and investment in the heart of the African miracle. Cultural Anthropology 24 (4): 652-680.